Mirogabalin inhibits scratching behavior of spontaneous model mouse of atopic dermatitis

Keyphrases

• Atopic Dermatitis 100%
• Scratching Behavior 100%
• Mirogabalin 100%
• Spontaneous Model 100%
• Motor Function 22%
• Chronic Itch 22%
• Healthy Mice 22%
• Gabapentin 22%
• Pregabalin 22%
• Antipruritic Effect 22%
• Gabapentinoids 22%
• Locomotor Activity 11%
• Treatment Options 11%
• Mouse Model 11%
• Clinical Treatment 11%
• Novel Therapeutics 11%
• Oral Administration 11%
• Spinal Dorsal Horn 11%
• Animal Experiment 11%
• Neuropathic Pain 11%
• Molecular Targets 11%
• New Therapeutic Agents 11%
• Analgesic Effect 11%
• Intracisternal Injection 11%
• Coordinated Movement 11%
• Economic Challenges 11%
• Safety Margin 11%
• Activity Wheel 11%

Pharmacology, Toxicology and Pharmaceutical Science

• Mouse Model 100%
• Atopic Dermatitis 100%
• Mirogabalin 100%
• Side Effect 33%
• Pruritus 22%
• Gabapentin 22%
• Pregabalin 22%
• Antipruritic Agent 22%
• Gabapentinoid 22%
• Disease 11%
• Analgesic Agent 11%
• Neuropathic Pain 11%

Medicine and Dentistry

• Atopic Dermatitis 100%
• Mirogabalin 100%
• Side Effect 33%
• Motor Performance 22%
• Pruritus 22%
• Gabapentin 22%
• Therapeutic Agent 22%
• Pregabalin 22%
• Antipruritic 22%
• Gabapentinoid 22%
• Disease 11%
• Oral Drug Administration 11%
• Neuropathic Pain 11%
• Locomotion 11%
• Horn 11%
• Analgesic Activity 11%
• Intracisternal Drug Administration 11%